Cetus said it was awarded five more patents.
- Share via
The Emeryville, Calif.-based biotechnology company said one of the patents was its third in interleukin-2, a protein that has shown promise as a potential treatment for cancer. The other patents were for a hybrid protein of interferon, also cited as a potential treatment for cancer and infectious diseases, and an enzyme and related methods involving the production of fructose, a form of sugar.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
